A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

NCT00975052 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: metformin
DRUG: Comparator: sitagliptin and metformin
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC